NIH-funded research NIH-funded research

How a protein called MDC1 helps repair DNA damage in cells

Official title: Molecular regulation of double-strand break repair by MDC1

Funded at Wayne State University · NIH-11278376 · Data updated 2026-11-12

This study is looking at how a protein called MDC1 helps fix broken DNA in our cells, which is really important for keeping our genes healthy, and it could help us find new treatments for cancer.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWayne State University
NIH-funded
Lab location1 site (Detroit, United States)
Project startDecember 1, 2023
Project endFebruary 29, 2028
Funding year2025
Award (this year)$249,000
NIH project number4R00GM149942-03
Project IDNIH-11278376 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with genetic predispositions to cancer, particularly those with mutations in DNA repair genes like BRCA1.

Less likely to help

Patients with conditions unrelated to DNA repair mechanisms or those without genetic predispositions to cancer may not benefit from this research.

What this research studies

This research investigates the role of the MDC1 protein in repairing DNA double-strand breaks, which are critical for maintaining genomic integrity. The study focuses on understanding how MDC1 interacts with other proteins and chromatin to facilitate two main repair pathways: Homologous Recombination (HR) and Non-Homologous End Joining (NHEJ). Using advanced imaging techniques, researchers aim to uncover the mechanisms by which MDC1 promotes these repair processes, particularly its unique functions that do not rely on the well-known BRCA1 protein. This research could provide insights into how cells respond to DNA damage, which is crucial for developing new therapies for conditions like cancer.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for enhancing DNA repair mechanisms, potentially benefiting patients with cancer by informing new treatment approaches.

How similar studies have gone: Other research has shown promising results in understanding DNA repair mechanisms, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Wayne State University
    Detroit, United States
    Active

Researchers

  • Principal investigator: Heyza, Joshua — Wayne State University
  • Study coordinator: Heyza, Joshua

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.